Siren, L.L.C. Arrowhead Pharmaceuticals, Inc. Transaction History
Siren, L.L.C.
- $1.93 Trillion
- Q2 2025
A detailed history of Siren, L.L.C. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 2,669,880 shares of ARWR stock, worth $47.5 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
2,669,880
Previous 2,669,880
-0.0%
Holding current value
$47.5 Million
Previous $34 Billion
24.02%
% of portfolio
2.18%
Previous 1.92%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
318Shares Held
99MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$279 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$276 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$189 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$113 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$93.1 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.88B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...